To elucidate the molecular mechanism of TRIM31-mediated anti-tumor function in breast cancer, we used proteomics and coimmunoprecipitation-mass spectrometry (MS) to characterize the specific substrate proteins of TRIM31 (Fig. 3a). This evidence concerns the gene TRIM31 and neoplasm.